Biosciences company secures $31m private placement

Prosetta Biosciences looks at cell-free protein synthesising systems to find new treatments for animal and human diseases like rabies.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this